Literature DB >> 17000969

Age, gender, and education norms on the CERAD neuropsychological battery in the oldest old.

M S Beeri1, J Schmeidler, M Sano, J Wang, R Lally, H Grossman, J M Silverman.   

Abstract

OBJECTIVE: To evaluate the performance of nondemented subjects 85 years and older on the Consortium to Establish a Registry for Alzheimer's Disease (CERAD) neuropsychological battery, and to assess its relationship with sociodemographic variables.
METHODS: We studied 196 subjects enrolled in an Alzheimer's Disease Research Center study who had a complete CERAD neuropsychological assessment. We used multiple regression analysis to predict performance on the neuropsychological tests from age, education, and sex. Eight representative hypothetical individuals were created (for example, an 87-year-old man, with high education). For each test, estimates of performance at the 10th, 25th, 50th, and 75th percentiles were reported for the eight representative hypothetical individuals.
RESULTS: Mean age was 89.2 years (SD = 3.2), mean years of education was 14.9 (SD = 3.2), and 66% of the sample were women. For 11 of the 14 neuropsychological tests, there was a significant multiple regression model using education, age, and sex as predictors. Neither the models nor the predictors used individually were significant for Delayed Recall, Savings, or correct Recognition. Among the significant results, seven had education as the strongest predictor. Lower age and higher education were associated with better performance. Women performed better than men in three of four tests with significant results for sex.
CONCLUSIONS: In a sample of oldest old whose primary language is English, neuropsychological testing is influenced mainly by education and age. Cutoff scores based on younger populations and applied to the oldest old might lead to increased false-positive misclassifications.

Entities:  

Mesh:

Year:  2006        PMID: 17000969      PMCID: PMC3163090          DOI: 10.1212/01.wnl.0000237548.15734.cd

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  15 in total

1.  Performance of elderly African American and White community residents on the CERAD Neuropsychological Battery.

Authors:  G G Fillenbaum; A Heyman; M S Huber; M Ganguli; F W Unverzagt
Journal:  J Int Neuropsychol Soc       Date:  2001-05       Impact factor: 2.892

2.  Detection and staging of dementia in Alzheimer's disease. Use of the neuropsychological measures developed for the Consortium to Establish a Registry for Alzheimer's Disease.

Authors:  K A Welsh; N Butters; J P Hughes; R C Mohs; A Heyman
Journal:  Arch Neurol       Date:  1992-05

3.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part V. A normative study of the neuropsychological battery.

Authors:  K A Welsh; N Butters; R C Mohs; D Beekly; S Edland; G Fillenbaum; A Heyman
Journal:  Neurology       Date:  1994-04       Impact factor: 9.910

4.  The Alzheimer's disease assessment scale: an instrument for assessing treatment efficacy.

Authors:  R C Mohs; W G Rosen; K L Davis
Journal:  Psychopharmacol Bull       Date:  1983

5.  Effects of age, gender, and education on cognitive tests in a rural elderly community sample: norms from the Monongahela Valley Independent Elders Survey.

Authors:  M Ganguli; G Ratcliff; F J Huff; S Belle; M J Kancel; L Fischer; E C Seaberg; L H Kuller
Journal:  Neuroepidemiology       Date:  1991       Impact factor: 3.282

6.  Estimating the validity of the clinical Dementia Rating Scale: the CERAD experience. Consortium to Establish a Registry for Alzheimer's Disease.

Authors:  G G Fillenbaum; B Peterson; J C Morris
Journal:  Aging (Milano)       Date:  1996-12

7.  Performance of elderly Native Americans and Caucasians on the CERAD Neuropsychological Battery.

Authors:  Shannon R Whyte; C Munro Cullum; Linda S Hynan; Laura H Lacritz; Roger N Rosenberg; Myron F Weiner
Journal:  Alzheimer Dis Assoc Disord       Date:  2005 Apr-Jun       Impact factor: 2.703

8.  Applicability of the CERAD neuropsychological battery to Brazilian elderly.

Authors:  P H Bertolucci; I H Okamoto; S M Brucki; M O Siviero; J Toniolo Neto; L R Ramos
Journal:  Arq Neuropsiquiatr       Date:  2001-09       Impact factor: 1.420

9.  Neuropsychological test performance in a cognitively intact sample of older Japanese American adults.

Authors:  S M McCurry; L E Gibbons; J M Uomoto; M L Thompson; A B Graves; S D Edland; J Bowen; W C McCormick; E B Larson
Journal:  Arch Clin Neuropsychol       Date:  2001-07       Impact factor: 2.813

10.  Population-based norms for the Mini-Mental State Examination by age and educational level.

Authors:  R M Crum; J C Anthony; S S Bassett; M F Folstein
Journal:  JAMA       Date:  1993-05-12       Impact factor: 56.272

View more
  42 in total

1.  Serum concentration of an inflammatory glycotoxin, methylglyoxal, is associated with increased cognitive decline in elderly individuals.

Authors:  Michal Schnaider Beeri; Erin Moshier; James Schmeidler; James Godbold; Jaime Uribarri; Sarah Reddy; Mary Sano; Hillel T Grossman; Weijing Cai; Helen Vlassara; Jeremy M Silverman
Journal:  Mech Ageing Dev       Date:  2011-11-03       Impact factor: 5.432

Review 2.  Diagnosing dementia in the oldest-old.

Authors:  Carrie Brumback-Peltz; Archana B Balasubramanian; María M Corrada; Claudia H Kawas
Journal:  Maturitas       Date:  2011-08-09       Impact factor: 4.342

3.  The neuropsychological performance of nondemented Puerto Rican nonagenarians.

Authors:  José R Carrión-Baralt; Josefina Meléndez-Cabrero; Michal Schnaider Beeri; Mary Sano; Jeremy M Silverman
Journal:  Dement Geriatr Cogn Disord       Date:  2009-03-17       Impact factor: 2.959

4.  C-reactive protein and memory function suggest antagonistic pleiotropy in very old nondemented subjects.

Authors:  Jeremy M Silverman; Michal Schnaider Beeri; James Schmeidler; Clive Rosendorff; Gary Angelo; Rizalina S Mavris; Hillel T Grossman; Gregory A Elder; Jose Carrion-Baralt; Rebecca West
Journal:  Age Ageing       Date:  2009-01-15       Impact factor: 10.668

5.  A computational linguistic measure of clustering behavior on semantic verbal fluency task predicts risk of future dementia in the nun study.

Authors:  Serguei V S Pakhomov; Laura S Hemmy
Journal:  Cortex       Date:  2013-06-14       Impact factor: 4.027

6.  [CERAD-NP battery: Age-, gender- and education-specific reference values for selected subtests. Results of the German Study on Ageing, Cognition and Dementia in Primary Care Patients (AgeCoDe)].

Authors:  T Luck; S G Riedel-Heller; B Wiese; J Stein; S Weyerer; J Werle; H Kaduszkiewicz; M Wagner; E Mösch; T Zimmermann; W Maier; H Bickel; H van den Bussche; F Jessen; A Fuchs; M Pentzek
Journal:  Z Gerontol Geriatr       Date:  2009-07-30       Impact factor: 1.281

7.  Haemoglobin A(1c) and cognitive function in very old, cognitively intact men.

Authors:  Jennifer Huang; James Schmeidler; Michal S Beeri; Clive Rosendorff; Simmi Bhatia; Rebecca K West; Irina N Bespalova; Rizalina Mavris; Jeremy M Silverman
Journal:  Age Ageing       Date:  2011-09-18       Impact factor: 10.668

Review 8.  Operationalizing diagnostic criteria for Alzheimer's disease and other age-related cognitive impairment-Part 1.

Authors:  Richard Mayeux; Christiane Reitz; Adam M Brickman; Mary N Haan; Jennifer J Manly; M Maria Glymour; Christopher C Weiss; Kristine Yaffe; Laura Middleton; Hugh C Hendrie; Lauren H Warren; Kathleen M Hayden; Kathleen A Welsh-Bohmer; John C S Breitner; John C Morris
Journal:  Alzheimers Dement       Date:  2011-01       Impact factor: 21.566

9.  Distinct age-related associations for body mass index and cognition in cognitively healthy very old veterans.

Authors:  James Schmeidler; Cecilia N Mastrogiacomo; Michal S Beeri; Clive Rosendorff; Jeremy M Silverman
Journal:  Int Psychogeriatr       Date:  2019-02-05       Impact factor: 3.878

10.  Ethnicity/culture modulates the relationships of the haptoglobin (Hp) 1-1 phenotype with cognitive function in older individuals with type 2 diabetes.

Authors:  Elizabeth Guerrero-Berroa; Ramit Ravona-Springer; Anthony Heymann; James Schmeidler; Hadas Hoffman; Rachel Preiss; Keren Koifmann; Lior Greenbaum; Andrew Levy; Jeremy M Silverman; Derek Leroith; Mary Sano; Michal Schnaider-Beeri
Journal:  Int J Geriatr Psychiatry       Date:  2015-09-21       Impact factor: 3.485

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.